Evidence map›Paper›PMID 36213206›Full record

ArticleFrontiers in neural circuits2022

Axonal α7* nicotinic acetylcholine receptors modulate glutamatergic signaling and synaptic vesicle organization in ventral hippocampal projections.

Chongbo Zhong, Wendy Akmentin, Lorna W Role, David A Talmage

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neural circuits, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Chongbo ZhongNational Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD, United States.
Wendy AkmentinDepartment of Neurobiology and Behavior, Center for Nervous System Disorders, Stony Brook University, Stony Brook, NY, United States.
Lorna W RoleNational Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD, United States.
David A TalmageNational Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Bethesda, MD, United States.
National Institutes of Health · USNational Institute of Neurological Disorders and Stroke · USStony Brook University · US

Funding

MODULATORY EFFECTS OF SUBSTANCE P ON AUTONOMIC NEURONSR01NS022061 · NINDS · STATE UNIVERSITY NEW YORK STONY BROOK · PI PLOTKIN, JOSHUA L · 1985 to 2019
$9.6M
NINDS NIH HHS R01 NS022061
6 · The paper itself

Abstract

Modulation of the release of glutamate by activation of presynaptic nicotinic acetylcholine receptors (nAChRs) is one of the most prevalent mechanism of nicotinic facilitation of glutamatergic transmission in cortico-limbic circuits. By imaging gene chimeric co-cultures from mouse, we examined the role of α7* nAChRs mediated cholinergic modulation of glutamate release and synaptic vesicle organization in ventral hippocampal projections. We directly visualized exogenous and endogenous cholinergic facilitation of glutamate release in this specialized preparation of circuits

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorReceptors, NicotinicAnimalsAxonsCholinergic AgentsGlutamic AcidHippocampusMiceSynaptic TransmissionSynaptic Vesiclesalpha7 Nicotinic Acetylcholine ReceptorCholinergic AgentsGlutamic AcidReceptors, Nicotiniccholinergic modulationelectron microscopyglutamatergic transmissioniGluSnFrneurotransmitter releaseoptogeneticssynaptic vesicle fusionα7* nicotinic acetylcholine receptor

Identifiers

PMID36213206
PMCPMC9537472
OpenAlexW4297005964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.